In conclusion, our findings reveal a previously unknown signal relay by which SH3KBP1 mediates EGFR activation, thereby enhancing the oncogenic activity of the EGFR signaling pathway in human gliomas. This evidence concerns the gene SH3KBP1 and central nervous system cancer.